Cargando...
Low Dose Naltrexone and Lung Cancer: A Case Report and Discussion
Low dose naltrexone (LDN) has been promising as a complementary medication for patients with a broad range of medical disorders. Although not a proven cure, evidence from clinical trials supports LDN as being a valuable adjunct for disorders in which the immune system plays a centralized role. Addit...
Guardado en:
| Publicado en: | Cureus |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Cureus
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6126779/ https://ncbi.nlm.nih.gov/pubmed/30197847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.2924 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|